Literature DB >> 30786118

Nationwide epidemiologic survey of Kawasaki disease in Japan, 2015-2016.

Nobuko Makino1, Yosikazu Nakamura1, Mayumi Yashiro1, Koki Kosami1, Yuri Matsubara1, Ryusuke Ae1, Yasuko Aoyama1, Hiroshi Yanagawa1.   

Abstract

BACKGROUND: Approximately 50 years have passed since Kawasaki disease (KD) was first reported. The KD nationwide survey began in 1970. Although >360 000 cases have already been reported in Japan, the cause is still unknown. In Japan, the number of patients and incidence rate of KD has continued to increase. It is necessary to examine the trend of the occurrence in the surveillance of KD.
METHODS: The nationwide survey of patient incidence in 2015 and 2016 was conducted in 2017, as the 24th nationwide survey of KD. A questionnaire was sent to pediatric departments in hospitals with >100 beds and specialized pediatric hospitals, and was responded to by the attending pediatricians.
RESULTS: The total number of patients in 2 years was 31 595, and the sex ratio (male/female) was 1.34. The incidence rate (/100 000 children aged 0-4 years/year) was 330.2 (371.2 in boys, 287.3 in girls) in 2015, and 309.0 (343.2 in boys, 273.2 in girls) in 2016. The number of patients by month peaked in January. The age-specific incidence rate according to sex was highest in children between 9 and 11 months of age, after which the incidence rate gradually decreased with advancing age.
CONCLUSIONS: We summarize the most recent nationwide survey of KD and consider the change in the epidemiologic picture.
© 2019 Japan Pediatric Society.

Entities:  

Keywords:  Kawasaki disease; cardiovascular complications; i.v. immunoglobulin therapy; incidence rate; mucocutaneous lymph node syndrome

Mesh:

Substances:

Year:  2019        PMID: 30786118     DOI: 10.1111/ped.13809

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  48 in total

1.  Mapping the Trends of Kawasaki Disease in Hawai'i from 1996 to 2018.

Authors:  Trenton J Dawson; Cindy T Vuong; Shani C Y Ma; Chad R Russell; Marian E Melish; Andras Bratincsak
Journal:  Hawaii J Health Soc Welf       Date:  2020-05-01

2.  A Protein Epitope Targeted by the Antibody Response to Kawasaki Disease.

Authors:  Anne H Rowley; Susan C Baker; David Arrollo; Leah J Gruen; Tetyana Bodnar; Nancy Innocentini; Matthew Hackbart; Yazmin E Cruz-Pulido; Kristine M Wylie; Kwang-Youn A Kim; Stanford T Shulman
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

Review 3.  Immune pathogenesis of COVID-19-related multisystem inflammatory syndrome in children.

Authors:  Anne H Rowley; Stanford T Shulman; Moshe Arditi
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

4.  Differences in Sensitivity Between the Japanese and Z Score Criteria for Detecting Coronary Artery Abnormalities Resulting from Kawasaki Disease.

Authors:  Ryusuke Ae; Yoshihide Shibata; Tohru Kobayashi; Koki Kosami; Masanari Kuwabara; Nobuko Makino; Yuri Matsubara; Teppei Sasahara; Hiroya Masuda; Yosikazu Nakamura
Journal:  Pediatr Cardiol       Date:  2022-09-19       Impact factor: 1.838

5.  Non-coronary cardiac events, younger age, and IVIG unresponsiveness increase the risk for coronary aneurysms in Italian children with Kawasaki disease.

Authors:  Marianna Fabi; Laura Andreozzi; Ilaria Frabboni; Ada Dormi; Elena Corinaldesi; Francesca Lami; Cristina Cicero; Bertrand Tchana; Rosa Francavilla; Monica Sprocati; Barbara Bigucci; Claudia Balsamo; Paola Sogno Valin; Giorgia Di Fazzio; Lorenzo Iughetti; Enrico Valletta; Federico Marchetti; Andrea Donti; Marcello Lanari
Journal:  Clin Rheumatol       Date:  2020-09-16       Impact factor: 2.980

6.  Characteristics and trends in diagnosis of Kawasaki disease outside the usual age range.

Authors:  Qu-Ming Zhao; Min Huang; Mei-Rong Huang; Sun Chen; Fang Liu; Guo-Ying Huang
Journal:  Clin Rheumatol       Date:  2020-08-26       Impact factor: 2.980

7.  American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 2.

Authors:  Lauren A Henderson; Scott W Canna; Kevin G Friedman; Mark Gorelik; Sivia K Lapidus; Hamid Bassiri; Edward M Behrens; Anne Ferris; Kate F Kernan; Grant S Schulert; Philip Seo; Mary Beth F Son; Adriana H Tremoulet; Rae S M Yeung; Amy S Mudano; Amy S Turner; David R Karp; Jay J Mehta
Journal:  Arthritis Rheumatol       Date:  2021-02-15       Impact factor: 10.995

8.  TNF-α blockers for the treatment of Kawasaki disease in children.

Authors:  Noyuri Yamaji; Katharina da Silva Lopes; Tetsuo Shoda; Kazue Ishitsuka; Tohru Kobayashi; Erika Ota; Rintaro Mori
Journal:  Cochrane Database Syst Rev       Date:  2019-08-16

9.  The occurrence of coronary artery lesions in Kawasaki disease based on C-reactive protein levels: a retrospective cohort study.

Authors:  Hyo Soon An; Gi Beom Kim; Mi Kyoung Song; Sang Yun Lee; Hye Won Kwon; Joo Won Lee; Eun Jung Bae
Journal:  Pediatr Rheumatol Online J       Date:  2021-06-02       Impact factor: 3.054

10.  Importance of blood pressure control in Kawasaki disease with expanded multiple giant coronary aneurysms with a 32 mm maximum diameter: a case report.

Authors:  Yuji Moritoh; Masahiro Kamada; Shinsaku Matsumoto; Koji Kido
Journal:  Eur Heart J Case Rep       Date:  2021-06-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.